|
Merck Wins Another Lawsuit for Fosamax Liability
A federal court has dismissed allegations that Merck’s osteoporosis drug Fosamax causes jaw bone destruction, two months after declaring a mistrial
in a similar suit involving Fosamax liability.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives